MedTrace Logo

A2 GUM Post-Market Effectiveness Study

NCT03698058 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 387

Last updated 2020-07-07

No results posted yet for this study

Summary

This is a post-market, real-life effectiveness study of A2 growing up milk on toddlers' gut comfort.

Conditions

  • Protein Intolerance

Interventions

DIETARY_SUPPLEMENT

Toddler milk

Commercially available toddler milk

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-15
Primary Completion
2019-02-28
Completion
2019-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03698058 on ClinicalTrials.gov